$28.96
-1.79 (-5.82%)
Open$30.95
Previous Close$30.75
Day High$30.95
Day Low$28.55
52W High$35.00
52W Low$5.90
Volume—
Avg Volume87.3K
Market Cap346.80M
P/E Ratio—
EPS$-31.22
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
-72.6% upside
Current
$28.96
$28.96
Target
$7.94
$7.94
$5.53
$7.94 avg
$9.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.57M | 8.53M | 49.01M |
| Net Income | -387,578,509 | -534,345,370 | -2,802,997 |
| Profit Margin | -6,960.8% | -6,612.7% | -5.7% |
| EBITDA | -391,554,275 | -569,817,036 | -4,562,575 |
| Free Cash Flow | — | — | -4,055,082 |
| Rev Growth | -34.7% | -34.7% | +7.4% |
| Debt/Equity | — | — | 0.82 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |